ANSWER: Denosumab (Prolia) is a treatment for osteoporosis that is normally given as an injection every six months. Among its ...

Prolia (denosumab) is a medication for osteoporosis. A healthcare professional administers Prolia via injection under the skin every 6 months. Medicare covers Prolia for beneficiaries. Since a ...

The Food and Drug Administration has approved Teva's Prolia biosimilar, and the agency is reviewing Teva's Xolair biosimilar application. “The FDA approval of Ponlimsi is a significant milestone that ...

LOS ANGELES (Reuters) - Amgen Inc's Prolia bone drug continues to improve bone mineral density in post-menopausal women treated with the drug for up to five years, according to new data released on ...